How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial

Written By Krista Verlis

Hersch J, McGeechan K, Barratt A, Jansen J, Irwig L, Jacklyn G, Houssami N, Dhillon H, McCaffery K.

Hersch J, McGeechan K, Barratt A, Jansen J, Irwig L, Jacklyn G, Houssami N, Dhillon H, McCaffery K. How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial. BMJ Open. 2017 Oct 6;7(10):e016246. doi: 10.1136/bmjopen-2017-016246.

Krista Verlis
Previous

Avoiding harm and supporting autonomy are under-prioritised in cancer-screening policies and practices
Next

Quantifying low-value care: a patient-centric versus service-centric lens